JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshinaga, K.
Right arrow Articles by Tamaki, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshinaga, K.
Right arrow Articles by Tamaki, N.
Journal of Nuclear Medicine Vol. 42 No. 6 838-844
© 2001 by Society of Nuclear Medicine


CLINICAL INVESTIGATIONS

Low-Dose Dobutamine Electrocardiograph-Gated Myocardial SPECT for Identifying Viable Myocardium: Comparison with Dobutamine Stress Echocardiography and PET

Keiichiro Yoshinaga, Koichi Morita, Satoshi Yamada, Kaoru Komuro, Chietsugu Katoh, Yoshinori Ito, Yuji Kuge, Tetsuro Kohya, Akira Kitabatake and Nagara Tamaki

Departments of Nuclear Medicine, Cardiovascular Medicine, and Tracer Kinetics, Hokkaido University School of Medicine, Sapporo, Japan

The identification of severely dysfunctional but viable myocardium is of particular importance for the selection of patients with depressed left ventricular function who will benefit from coronary revascularization. Assessment of inotropic reserve with dobutamine has recently been used for this purpose. This study compared the accuracy of low-dose dobutamine stress gated myocardial SPECT (DS SPECT) with the accuracy of dobutamine stress echocardiography (DSE) and resting perfusion SPECT for the identification of viable myocardium in patients with previous myocardial infarction. Methods: Resting and low-dose dobutamine (7.5 µg/kg/min) gated 99mTc-tetrofosmin SPECT and echocardiography and resting 18F-FDG PET were prospectively studied in 23 patients with previous myocardial infarction and severely depressed regional function. Twenty-one of them were successfully studied with each technique. The left ventricular wall was divided into 14 segments to assess wall motion using a 5-point scale. PET viability was defined as FDG uptake >= 50% of the maximum uptake in a region with normal wall motion. For DS SPECT and DSE studies, viable myocardium was defined as hypokinetic areas with >=1 point improvement in wall motion. For resting perfusion SPECT, viable myocardium was defined as hypokinetic areas with a relative uptake >= 50% of the maximum uptake. Results: Of a total of 294 segments, 55 had severe resting dyskinesis. Thirty-four segments were identified as viable on FDG PET, and 21 segments were identified as nonviable. Eleven segments were inadequately visualized with DSE, including 5 segments in the apex. Sensitivities (78% vs. 76%) and specificities (94% vs. 100%) were similar for DSE and DS SPECT, with a concordance of 86% ({kappa} = 0.72). DS SPECT and perfusion SPECT did not significantly differ with respect to sensitivities (76% vs. 85%, respectively). However, specificity was significantly higher for DS SPECT than for perfusion SPECT (100% vs. 52%, respectively, P < 0.05). Conclusion: This study indicated that DS SPECT correlates well with DSE in the assessment of viability. In addition, gated SPECT can evaluate regional wall motion, even in areas inadequately assessed by echocardiography. DS SPECT may also provide additional information for identifying viable myocardium, which is often overestimated by routine perfusion scans.

Key Words: myocardial viability • dobutamine • emission CT echocardiography • FDG




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
A. K. Paul and H. A. Nabi
Gated Myocardial Perfusion SPECT: Basic Principles, Technical Aspects, and Clinical Applications
J. Nucl. Med. Technol., December 1, 2004; 32(4): 179 - 187.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Yoshinaga, C. Katoh, R. S.B. Beanlands, K. Noriyasu, K. Komuro, S. Yamada, Y. Kuge, K. Morita, A. Kitabatake, and N. Tamaki
Reduced Oxidative Metabolic Response in Dysfunctional Myocardium with Preserved Glucose Metabolism but with Impaired Contractile Reserve
J. Nucl. Med., November 1, 2004; 45(11): 1885 - 1891.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. Go, M. R. Bhatt, and R. C. Hendel
The Diagnostic and Prognostic Value of ECG-Gated SPECT Myocardial Perfusion Imaging
J. Nucl. Med., May 1, 2004; 45(5): 912 - 921.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Matsunari, J. Taki, and N. Tonami
Sequential Strategy Using Multimodality Viability Tests: Does It Work?
J. Nucl. Med., June 1, 2002; 43(6): 803 - 805.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.